dr. crew on treatment in favorable-risk her2 breast cancer
Published 4 years ago • 141 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
1:49
dr. crew on updated data with margetuximab in her2 breast cancer
-
1:39
dr. crew on the aphinity trial results in her2 breast cancer
-
1:11
dr. crew on recent advances in her2 breast cancer
-
6:01
treating low-risk her2-positive breast cancer
-
1:53
dr. tolaney on navigating adjuvant therapy in early-stage her2 breast cancer
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
0:50
dr. ellis on immunotherapy in her2 breast cancer
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
1:51
dr. denduluri on treatment approaches in early-stage hr /her2- breast cancer
-
1:05
dr. hamilton on the evolution of treatment in her2 breast cancer
-
0:57
dr. mittendorf on the impact of pertuzumab in her2 breast cancer
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
1:20
dr. hurvitz on the evolution of treatment in metastatic her2 breast cancer
-
1:20
dr. barrio on treatment options for her2 breast cancer
-
1:32
dr. tolaney on the evolution of treatment in her2 breast cancer
-
3:48
her2 breast cancer: future treatment landscape
-
1:00
dr. ruddy on the management of cns metastases in her2 breast cancer
-
4:04
adjuvant therapy for high-risk her2 breast cancer
-
8:26
adjuvant strategies in early-stage her2 breast cancer